Seroprevalence and levels of IgG antibodies after COVID-19 infection or vaccination-Reference-Cited by-同舟云学术

Seroprevalence and levels of IgG antibodies after COVID-19 infection or vaccination

Published:2021-09-14 Issue:1 Volume:54 Page:63-71
ISSN:2374-4235
Container-title:Infectious Diseases
language:en
Short-container-title:Infectious Diseases

Author:

Soeorg Hiie¹,Jõgi Piia²³,Naaber Paul¹⁴,Ottas Aigar⁵,Toompere Karolin⁶,Lutsar Irja¹

Affiliation:

1. Department of Microbiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia

2. Children’s Clinic of Tartu University Hospital, Tartu, Estonia

3. Department of Pediatrics, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia

4. SYNLAB Estonia, Veerenni 53a, Tallinn, Estonia

5. Department of Biochemistry, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia

6. Department of Epidemiology and Biostatistics, Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia

Funder

the Ministry of Social Affairs of the Republic of Estonia

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/23744235.2021.1974540

Reference29 articles.

1. Estonian Health Board. Description of coronavirus COVID-19 open data. 2021. [cited May 5, 2021]. Available from: https://www.terviseamet.ee/et/koroonaviirus/avaandmed

2. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

3. Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

4. Risk factors for severe and critically ill COVID‐19 patients: A review

5. Jõgi P, Soeorg H, Ingerainen D, et al. Prevalence of SARS-CoV-2 IgG antibodies and their association with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study). Vaccine. 2021;39(38):5376–5384.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 N protein IgG antibody detection employing nanoporous anodized alumina: A rapid and selective alternative for identifying naturally infected individuals in populations vaccinated with spike protein (S)-based vaccines;Sensors and Actuators B: Chemical;2024-11

2. Seroprevalence of anti-SARS-CoV-2 IgG antibodies pre- and post-COVID-19 vaccination in staff members of Bandar Abbas Children’s Hospital;BMC Infectious Diseases;2024-02-23

3. Proportion of COVID-19 survivors in 2020-2022 in the Russian population (according to the ESSE-RF3 study);Cardiovascular Therapy and Prevention;2023-12-29

4. Antibody responses to mRNA versus non-mRNA COVID vaccines among the Mongolian population;IJID Regions;2023-09

5. Seroepidemiology of SARS-CoV-2 antibody and infection rate estimation following a high-intensity epidemic of COVID-19 in Guangdong Province, China: A large population cross-sectional investigation (Preprint);2023-09-01